Cronos (CRON) EBITDA Margin (2018 - 2026)

Cronos (CRON) recorded quarterly EBITDA Margin of 7.35% in Q1 2026, down 110.0% quarter-over-quarter from 73.5% in Q4 2025, and down 1843.0% on a YoY basis from 0.42% in Q1 2025.

Cronos (CRON) EBITDA Margin (2018 - 2026) Analysis & Trends

Cronos' EBITDA Margin history runs 9 years deep, the most recent figure standing at 7.35% for Q1 2026.

  • In Q1 2026, EBITDA Margin fell 1843.0% year-over-year to 7.35%; the TTM figure through Mar 2026 stood at 18.44% (up 3026.0% YoY), while the FY2025 annual figure was 25.4%, up 6477.0% from the prior year.
  • EBITDA Margin was 7.35% for Q1 2026 at Cronos, down from 73.5% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 73.5% in Q4 2025 to a low of 374.6% in Q3 2022.
  • Historically, EBITDA Margin has averaged 57.39% across 5 years, with a median of 48.91% in 2024.
  • Biggest YoY gain for EBITDA Margin was 94075 bps in 2022; the steepest drop was 59765 bps in 2022.
  • A 5-year view of EBITDA Margin shows it stood at 208.95% in 2022, then jumped by 82 bps to 38.64% in 2023, then tumbled by 93 bps to 74.62% in 2024, then jumped by 199 bps to 73.5% in 2025, then slumped by 110 bps to 7.35% in 2026.
  • The last three EBITDA Margin figures came in at 7.35% (Q1 2026), 73.5% (Q4 2025), and 1.41% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 16.37%
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 36.83%
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 41.69%
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -1.01%
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 22.74%
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 22.39%
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -170.35%
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 21.55%
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -16.25%
10 Cronos 1.06 Bn 284.85 Mn 19.15 Mn -7.35%

Historic Data

Download Data
DateValue
Mar 31, 2026 -7.35%
Dec 31, 2025 73.50%
Sep 30, 2025 1.41%
Jun 30, 2025 49.14%
Mar 31, 2025 11.08%
Dec 31, 2024 -74.62%
Sep 30, 2024 57.59%
Jun 30, 2024 -48.91%
Mar 31, 2024 -97.72%
Dec 31, 2023 -38.64%
Sep 30, 2023 -64.47%
Jun 30, 2023 31.67%
Mar 31, 2023 -63.43%
Dec 31, 2022 -208.95%
Sep 30, 2022 -374.60%
Jun 30, 2022 -164.68%
Mar 31, 2022 -56.71%
Dec 31, 2021 -834.53%
Sep 30, 2021 223.05%
Jun 30, 2021 -1,059.33%